Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirinMaria Trapero-Marugan
Gastroenterology Hepatology Department, University Hospital La Princesa and Princesa Research Institute, Autonomous University of Madrid and CIBERehd, C Diego de Leon 62, Madrid, Spain
World J Gastroenterol 17:493-8. 2011
..To assess the clinical, biochemical and virological long-term outcome in chronic hepatitis C (CHC) patients with a sustained virological response (SVR) after peginterferon (PEG-IFN) plus ribavirin combination therapy...
Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatmentM Trapero-Marugan
Gastroenterology and Hepatology Service, Hospital Universitario de la Princesa, Autonomous University of Madrid, and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
J Clin Pharm Ther 36:695-703. 2011
..Our objective was to assess the efficacy, safety and predictive factors for sustained virological response (SVR) to peginterferon plus ribavirin in chronic hepatitis C patients who failed to interferon-alfa (IFNα)-based therapy...
Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish centerM Trapero-Marugan
Gastroenterology and Hepatology Department, Hospital Universitario de la Princesa, Autonomous University of Madrid, Spain
J Chemother 19:423-7. 2007
..In conclusion, the lower stage of fibrosis, lower viremia and higher SVR rate than genotype 1 suggest a less aggressive pattern of diseased caused by this genotype...
- Treatment regimens for patients with chronic hepatitis C
M Trapero-Marugan
Digestive Diseases Department and CIBEREHD, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
Minerva Gastroenterol Dietol 54:209-17. 2008
....
- Combined antiviral options for the treatment of chronic hepatitis C
Jesus Medina
Unidad de Hepatología planta 3, Hospital Universitario de la Princesa, Universidad Autonoma, Diego de Leon 62, E 28006 Madrid, Spain
Antiviral Res 60:135-43. 2003
....
- Predictive graphical model, network-based medical tool for the prognosis of chronic hepatitis C patients treated with peg-interferon plus ribavirin
M Trapero-Marugan
Gastroenterology Hepatology Service and CIBEREHD, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
Aliment Pharmacol Ther 28:468-74. 2008
..There are few model networks to predict treatment outcome in viral hepatitis...
- Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy
J Mendoza
Service of Digestive Diseases and CIBERehd, University Hospital La Princesa, Universidad Autonoma, Madrid, Spain
Rev Esp Enferm Dig 102:426-34. 2010
..The efficacy of combination therapy with peginterferon plus ribavirin to eradicate viral infection in patients with chronic hepatitis C (CHC) is well established; moreover, it is able to arrest or even reverse liver fibrosis...
- Is interferon-beta an alternative treatment for chronic hepatitis C?
Ricardo Moreno-Otero
Unit of Hepatology, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
World J Gastroenterol 12:2730-6. 2006
..It might be worth assessing the value of IFNbeta plus ribavirin in randomized studies with a larger cohort of patients, not eligible or not tolerating standard therapy, and for non-responders...
- The colorectal carcinoma prognosis factors. Significance of diagnosis delay
E Gómez-Domínguez
Service of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
Rev Esp Enferm Dig 98:322-9. 2006
..The aim of this study was to establish whether a delay in diagnosis or other factors are related to CRC stage...
- Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature
Maria Chaparro
Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
J Crohns Colitis 7:e61-5. 2013
..Surveillance for colorectal cancer should be strongly recommended in this group of patients...
- [Hepatic disease in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease)]
Rosario Gonzalez-Casas
Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Espana
Med Clin (Barc) 129:629-31. 2007
- Evaluation of liver fibrosis by transient elastography in methotrexate treated patients
Almudena Barbero-Villares
Servicio de Aparato Digestivo y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
Med Clin (Barc) 137:637-9. 2011
....
- Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis
Ricardo Moreno-Otero
Service of Digestive Diseases and Ciberehd Planta 3, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Diego de Leon 62, 28006 Madrid, Spain
Curr Drug Saf 6:197-200. 2011
..A complete remission was achieved in this patient with corticosteroids therapy...
- Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma
Paloma Sanz-Cameno
Laboratory of Investigation, Molecular Biology Unit, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, 28006 Madrid, Spain
J Oncol 2010:272170. 2010
....
- Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase
R Moreno-Otero
Gut 55:1055-6. 2006
